MASH prevalence is rapidly increasing in parallel with increases in obesity and other cardio-renal-metabolic diseases. An interactive case will explore clinical challenges and unmet patient needs.
Industry Supporter: Boehringer Ingelheim International GmbH
Presentations
9:01 AM - 9:01 AM
Nov
17
2024
San Diego, CA
MASH Matters: The Evolving Management of Patients with Metabolic Dysfunction Associated Steatohepatitis
Kris V Kowdley, MD, FACP, FACG, AGAF, FAASLD, Industry Presenter